A PET/MRI study towards finding the optimal [18F]Fluciclovine PET protocol for detection and characterisation of primary prostate cancer.
Mattijs ElschotKirsten M SelnæsElise SandsmarkBrage Krüger-StokkeØystein StørkersenMay-Britt TessemSiver A MoestueHelena BertilssonTone F BathenPublished in: European journal of nuclear medicine and molecular imaging (2016)
Late-window [18F]Fluciclovine PET imaging shows promise for distinguishing between prostate tumours and benign tissue and for assessment of tumour aggressiveness.
Keyphrases
- pet imaging
- prostate cancer
- pet ct
- positron emission tomography
- radical prostatectomy
- computed tomography
- magnetic resonance imaging
- randomized controlled trial
- contrast enhanced
- big data
- machine learning
- real time pcr
- benign prostatic hyperplasia
- magnetic resonance
- label free
- artificial intelligence
- sensitive detection